Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page
- ChecktodayChange DetectedA new revision stamp (Revision: v3.6.6) was added, replacing the previous v3.6.5. This indicates a small, internal update to the page's platform without altering study details.SummaryDifference0.0%

- Check14 days agoChange DetectedAdded funding source information: '2018 ( U.S. NIH Grant/Contract )' appears under the study identifiers, clarifying NIH support for the trial. This provides context about who funded the study.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays revision v3.6.5, replacing v3.6.4. This indicates a minor backend/UI update to the page without modifying its content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a routine system update rather than changes to the study details.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the prior Revision: v3.6.0; this signals a newer version of the page is in effect.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates bibliographic references and versioning, while the Intervention/Treatment label is reformatted; the recruitment status is updated to No longer looking for participants.SummaryDifference0.3%

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.